The Use of the "Comprehensive Complication Index" for Urinary Lithiasis Surgery.

Sponsor
Sismanoglio General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05593783
Collaborator
(none)
400
1
20.3
19.7

Study Details

Study Description

Brief Summary

The study will be prospective non-interventional and will include patients with kidney stones who are to undergo one of the following three techniques: retrograde nephrolithotripsy, percutaneous nephrolithotripsy and extracorporeal nephrolithotripsy depending on the size of the stone. Data regarding post operative descriptions will be recorded and comprehensive complication index will be used for the assesment of the burden.

Condition or Disease Intervention/Treatment Phase
  • Procedure: lithotripsy

Detailed Description

The study will be prospective non-interventional and will include patients with kidney stones who are to undergo one of the following three techniques: retrograde nephrolithotripsy, percutaneous nephrolithotripsy and extracorporeal nephrolithotripsy depending on the size of the stone. The study will take place at the 2nd Urology Clinic of the University of Athens, at the Sismanoglio Hospital of Athens. It will include patients diagnosed with kidney stones after plain X-ray and/or CT scan. Percutaneous nephrolithotripsy will be performed on stones

2 cm, while extracorporeal or retrograde nephrolithotripsy on stones < 2 cm. Patient demographics (age, gender, body mass index, comorbidities, anticoagulant use), stone-related data (maximum stone size, anatomic location of stone, number of stones, presence of hydronephrosis preoperatively, presence of piglet catheter preoperatively, positive urine culture, preoperative chemoprophylaxis ) as well as information about the operation (type of anesthesia, operation time, hospitalization time) will be reported. Finally, all possible complications will be recorded intraoperatively, immediately postoperatively and up to 30 days after the day of surgery. This will be followed by a statistical analysis of the resulting data and a comparison between the CDC and CCI systems using the SPSS statistical program. To describe continuous variables, the mean/standard deviation will be used if it is a normal distribution, or the median and range if it is a non-normal distribution. The Shapiro-Wilk test will be used to investigate the distribution of the data. The absolute number and the corresponding percentage will be used to describe the qualitative variables. For the comparison of continuous variables, the parametric t-test will be used if the data follow a normal distribution, or the Mann-Whitney U test if they do not follow a normal distribution. Chi-square and Fisher's exact test will be used to compare qualitative variables. Exclusion criteria from this study are:

  1. Non-acceptance by the patient of his participation or inability to understand the purposes and procedures of the study.

  2. Recent similar operation that the patient has undergone (interval of less than one month).

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Use of the "Comprehensive Complication Index" as a Recording System of Postoperative Complications After Percutaneous, Retrograde and Extracorporeal Lithotripsy for Renal Lithiasis.
Actual Study Start Date :
Oct 21, 2022
Anticipated Primary Completion Date :
Jun 30, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
patients with lithiasis treated with ureterolithotripsy

patients with lithiasis treated with ureterolithotripsy

Procedure: lithotripsy
lithotripsy
Other Names:
  • percutaneous nephrolithotomy
  • extracorporeal shockwave lithotripsy
  • patients with lithiasis treated with percutaneous nephrolithotomy

    patients with lithiasis treated with percutaneous nephrolithotomy

    Procedure: lithotripsy
    lithotripsy
    Other Names:
  • percutaneous nephrolithotomy
  • extracorporeal shockwave lithotripsy
  • patients with lithiasis treated with extracorporeal shockwave lithotripsy

    patients with lithiasis treated with extracorporeal shockwave lithotripsy

    Procedure: lithotripsy
    lithotripsy
    Other Names:
  • percutaneous nephrolithotomy
  • extracorporeal shockwave lithotripsy
  • Outcome Measures

    Primary Outcome Measures

    1. comprehensive complication index score [1,5 year]

      reporting postoperative complications with clavien dindo and comprehensive complication index and comparison of those two.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Patients with urinary lithiasis undergoing ureterolithotripsy, percutaneous nephrolithotripsy or extracorporeal shockwave lithotripsy.

    Exclusion Criteria:
      1. Non-acceptance by the patient of his participation or inability to understand the purposes and procedures of the study.
    1. Recent similar operation that the patient has undergone (interval of less than one month).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sismanoglio General Hospital Athens Marousi Greece 15126

    Sponsors and Collaborators

    • Sismanoglio General Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Stamatios Katsimperis, Dr Stamatios Katsimperis, Sismanoglio General Hospital
    ClinicalTrials.gov Identifier:
    NCT05593783
    Other Study ID Numbers:
    • 67127
    First Posted:
    Oct 25, 2022
    Last Update Posted:
    Oct 25, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Stamatios Katsimperis, Dr Stamatios Katsimperis, Sismanoglio General Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 25, 2022